Mereo Biopharma Group PLC
NASDAQ:MREO
Mereo Biopharma Group PLC
Selling, General & Administrative
Mereo Biopharma Group PLC
Selling, General & Administrative Peer Comparison
Competitive Selling, General & Administrative Analysis
Latest Figures & CAGR of Competitors
Company | Selling, General & Administrative | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Mereo Biopharma Group PLC
NASDAQ:MREO
|
Selling, General & Administrative
-£19.5m
|
CAGR 3-Years
-7%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
|
Selling, General & Administrative
-$53.7m
|
CAGR 3-Years
-261%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Autolus Therapeutics PLC
NASDAQ:AUTL
|
Selling, General & Administrative
-$54.9m
|
CAGR 3-Years
-10%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Bicycle Therapeutics PLC
NASDAQ:BCYC
|
Selling, General & Administrative
-$62.2m
|
CAGR 3-Years
-24%
|
CAGR 5-Years
-45%
|
CAGR 10-Years
N/A
|
|
Immunocore Holdings PLC
NASDAQ:IMCR
|
Selling, General & Administrative
-£144.5m
|
CAGR 3-Years
-47%
|
CAGR 5-Years
-38%
|
CAGR 10-Years
N/A
|
|
Genus PLC
LSE:GNS
|
Selling, General & Administrative
-£7.6m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
-9%
|
See Also
What is Mereo Biopharma Group PLC's Selling, General & Administrative?
Selling, General & Administrative
-19.5m
GBP
Based on the financial report for Dec 31, 2022, Mereo Biopharma Group PLC's Selling, General & Administrative amounts to -19.5m GBP.
What is Mereo Biopharma Group PLC's Selling, General & Administrative growth rate?
Selling, General & Administrative CAGR 3Y
-7%
Over the last year, the Selling, General & Administrative growth was -23%. The average annual Selling, General & Administrative growth rates for Mereo Biopharma Group PLC have been -7% over the past three years .